Endocrinology Update: Hirsutism

    December 2016 in “ PubMed ”
    Joel J. Heidelbaugh
    TLDR Hirsutism involves excessive hair growth due to hormonal issues and can be treated with medication or surgery.
    Hirsutism was defined as excessive terminal hair growth in androgen-dependent areas, often following a male pattern, and could affect both men and women. Common causes included polycystic ovary syndrome, idiopathic hyperandrogenemia, adrenal hyperplasia, androgen-secreting tumors, and various endocrine disorders. Diagnostic guidelines primarily targeted premenopausal women, but evaluations for underlying conditions in postmenopausal women and men were also necessary. Management focused on eliminating causative drugs, assessing hormonal dysregulation, and identifying tumors. Treatment options included hormonal therapies, antiandrogens, and surgical interventions for tumors.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 25 results

      community I am having Success with RU58841 and 1mm Derma Roller

      in Microneedling  19 upvotes 2 years ago
      A user reported success with RU58841 and a 1mm derma roller for hair regrowth, noting significant improvement in hair density and reduced scalp visibility. They also mentioned using minoxidil and black castor oil in the past, with mixed results.

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Finasteride 5mg & Spironolactone 100mg

      in Female  2 upvotes 4 weeks ago
      A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 3 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

    Related Research

    1 / 1 results